Fundraising Fox
Montara Therapeutics
San Francisco, US · Founded 2022 · Delaware corporation · 25 employees on LinkedIn · 6 known investors
Find your way into Montara Therapeutics
Sign up to see every warm intro you have to Montara Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Montara Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Montara is a biotech company developing small-molecule therapeutics focused on neurodegeneration and diseases such as Alzheimer's. It was founded by scientists whose prior company, Mitokinin, was acquired by AbbVie in 2023.
Founders & leadership
Montara Therapeutics was founded in 2022 by Kevan Shokat and Thomas Südhof.
Investors · 6
How we know: Dolby Family Ventures's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: SV Health Investors's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: funding news · the VCSheet dataset · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$28M disclosed across 2 rounds · 2024–2025
▶$20MraisedMar 2025 · 9 investors · BiotechnologyRule 506(b)
- Max LebovitzExecutive Officer
- Seth StrattonDirector
- Troy WilsonDirector
- Zachary HillExecutive Officer
- Rishi RakhitExecutive Officer
- Randall ChinExecutive Officer
- Dirk LangdorfDirector
- Nicholas HertzExecutive Officer, Director, Promoter
- Offering amount
- $20M
- Amount sold
- $20M
- First sale
- Feb 2025
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$8MraisedJan 2024 · 5 investors · BiotechnologyRule 506(b)
- Seth StrattonDirector
- Dirk LangdorfDirector
- Nicholas HertzExecutive Officer, Director
- Offering amount
- $17M
- Amount sold
- $8M
- First sale
- Jan 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Montara Therapeutics went on to found or lead other companies.
Related companies · 2
Companies working in the same space as Montara Therapeutics.
In the news
Frequently asked questions
- What does Montara Therapeutics do?
- Montara is a biotech company developing small-molecule therapeutics focused on neurodegeneration and diseases such as Alzheimer's. It was founded by scientists whose prior company, Mitokinin, was acquired by AbbVie in 2023.
- Who founded Montara Therapeutics?
- Montara Therapeutics was founded by Kevan Shokat, Thomas Südhof in 2022.
- Who are Montara Therapeutics's investors?
- Montara Therapeutics's investors include BEVC, Dolby Family Ventures, SV Health Investors, Two Bear Capital, Dementia Discovery Fund, KdT Ventures.
- How much funding has Montara Therapeutics raised?
- Montara Therapeutics has disclosed $28M raised across 2 rounds.
- Where is Montara Therapeutics headquartered?
- Montara Therapeutics is headquartered in San Francisco, US.